Channels - Multiple omics analyses and experiments validation identify PRDX3 as a biomarker of prognosis and antioncogene in kidney clear cell carcinoma

Similar Items: Multiple omics analyses and experiments validation identify PRDX3 as a biomarker of prognosis and antioncogene in kidney clear cell carcinoma

Quick Look
NUP85 as a Pan-Cancer Immune Biomarker: Integrated Multi Omics and Functional Analyses Reveal Its Role in Tumor Prognosis
Quick Look
Multi-omics analysis reveals key genes associated with clear cell renal cell carcinoma
Quick Look
Identifying Prognostic Biomarkers and Key Pathways in Renal Clear Cell Carcinoma: A Pilot Study Using Integrated miRNA and Gene Expression Analysis
Quick Look
Multi-omics analysis and functional validation of CHEK1 as an independent prognostic biomarker in Pancreatic cancer
Quick Look
Immune-activated & pathology-characterized: the distinct clear cell renal cell carcinoma subtypes for 3PM strategies derived from artificial intelligence in multi-omics
Quick Look
Spatial omics and AI for clinically actionable cancer biomarkers
Quick Look
Integrated multi-omics analysis identifies TBC1D10C as an NK- and T cell-associated diagnostic biomarker in childhood obesity
Quick Look
Correction: Met Is the Most Frequently Amplified Gene in Endometriosis-Associated Ovarian Clear Cell Adenocarcinoma and Correlates with Worsened Prognosis
Quick Look
Molecular classification and prognosis study of pancreatic ductal adenocarcinoma through multi-omics integrated clustering analysis
Quick Look
Biomarkers of mitochondrial dynamics in idiopathic pulmonary fibrosis: Identification and validation through transcriptomic and single-cell analyses
Quick Look
Long non-coding RNA PSMB8-AS1 as a potential biomarker for postoperative recurrence in patients with Fuhrman grades 1–3 clear cell renal cell carcinoma
Quick Look
The role of SPP1 in evaluating the prognosis, immune infiltration, and drug sensitivity of hepatocellular carcinoma
Quick Look
Blood protein biomarkers in hepatocellular carcinoma: progress and challenges
Quick Look
Omics BioAnalytics: an RShiny application for multimodal biomarker panel discovery and assessment
Quick Look
Whole‐transcriptome sequencing analyses identified exosomal circular RNAs in the plasma of pancreatic cancer patients as novel blood‐based biomarkers of disease
Quick Look
Deciphering diverse cell‐death patterns to predict the prognosis and potential therapy target of hepatocellular carcinoma patients
Quick Look
Retraction: RhoB Acts as a Tumor Suppressor That Inhibits Malignancy of Clear Cell Renal Cell Carcinoma
Quick Look
IL20RB promotes proliferation and migration in clear cell renal cell carcinoma and is associated with immune infiltration
Quick Look
Integrated serum proteomics and metabolomics reveal an INR-associated multi-omics signature in hepatocellular carcinoma
Quick Look
Molecular and Immunohistochemical Biomarkers in Colorectal Carcinoma - A Single Center Study
Quick Look
Expression of Concern: TMEM41A overexpression correlates with poor prognosis and immune alterations in patients with endometrial carcinoma
Quick Look
Transcriptomic profiling of clear cell renal cell carcinoma reveals age-dependent molecular signatures and clinical stratification patterns
Quick Look
Tumor-Promoting Crosstalk of MMP11⁺ Fibroblasts and SPP1⁺ Macrophages Drive Poor Prognosis in Breast Cancer: Integrated Multi-Omics Analysis
Quick Look
MOLECULAR PREDICTIVE BIOMARKERS FOR ORAL SQUAMOUS CELL CARCINOMA IN HUMANS IN IBADAN, NIGERIA